Overwhelming fatigue in advanced cancer.
Bruera
E
E
Cross Cancer Institute, Edmonton, Alberta, Canada.
MacDonald
R N
RN
D001247:Asthenia / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008454:Mazindol / Q000009:adverse effects / Q000627:therapeutic use; D008774:Methylphenidate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications*
D008774:Methylphenidate; D008454:Mazindol; D008775:Methylprednisolone